Geron (GERN) Current Assets (2010 - 2026)
Geron's (GERN) quarterly Current Assets came in at $498.5 million in Q1 2026, up 0.56% year-on-year from $495.8 million in Q1 2025, and down 4.18% quarter-over-quarter from $520.3 million in Q4 2025.
Geron (GERN) Current Assets (2010 - 2026) Analysis & Trends
Geron has disclosed Current Assets across 17 years of filings, most recently posting $498.5 million for Q1 2026.
- Current Assets for Q1 2026 came in at $498.5 million, up 0.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $498.5 million (up 0.56% YoY), and the FY2025 annual result was $520.3 million, up 5.96% from the prior year.
- Current Assets came in at $498.5 million for Q1 2026 at Geron, down from $520.3 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $522.3 million in Q3 2025 to a low of $175.9 million in Q1 2022.
- The 5-year median for Current Assets is $387.0 million (2023), against an average of $382.5 million.
- Across the five-year window, Current Assets dropped 18.28% in 2022 and jumped 119.99% in 2023, its largest moves.
- Geron's Current Assets stood at $180.2 million in 2022, then surged by 89.38% to $341.3 million in 2023, then soared by 43.84% to $491.0 million in 2024, then climbed by 5.96% to $520.3 million in 2025, then declined by 4.18% to $498.5 million in 2026.
- The last three Current Assets figures came in at $498.5 million (Q1 2026), $520.3 million (Q4 2025), and $522.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 600.85 Mn |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 498.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 498.53 Mn |
| Dec 31, 2025 | 520.27 Mn |
| Sep 30, 2025 | 522.34 Mn |
| Jun 30, 2025 | 505.60 Mn |
| Mar 31, 2025 | 495.77 Mn |
| Dec 31, 2024 | 490.99 Mn |
| Sep 30, 2024 | 398.06 Mn |
| Jun 30, 2024 | 373.31 Mn |
| Mar 31, 2024 | 451.51 Mn |
| Dec 31, 2023 | 341.35 Mn |
| Sep 30, 2023 | 335.09 Mn |
| Jun 30, 2023 | 377.28 Mn |
| Mar 31, 2023 | 387.02 Mn |
| Dec 31, 2022 | 180.25 Mn |
| Sep 30, 2022 | 222.07 Mn |
| Jun 30, 2022 | 227.38 Mn |
| Mar 31, 2022 | 175.92 Mn |
| Dec 31, 2021 | 187.21 Mn |
| Sep 30, 2021 | 179.36 Mn |
| Jun 30, 2021 | 201.76 Mn |